Exonic deletions of mismatch repair genes MLH1 and MSH2 correlate with prognosis and protein expression levels in malignant melanomas

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 1231-1235

  Korabiowska, Monika ^a,e   Brinck, Ulrich ^a   Stachura, Jerzy ^b   Jawien, Jacek ^b   Hasse, Frank Michael ^c   Cordon Cardo, Carlos ^d   Fischer, Gösta ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Herzogin Elisabeth Heim ^*  (Germany)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Institute of Pathology   (Germany)

Author keywords

Malignant melanoma; MLH1; MSH2; Mutation; Protein expression

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH2;

ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EXON; FEMALE; FOLLOW UP; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MELANOMA; MISMATCH REPAIR; MULTIVARIATE ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; UVEA MELANOMA;

BASE PAIR MISMATCH; CARRIER PROTEINS; DNA REPAIR; EXONS; GENE DELETION; HUMANS; MELANOMA; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; POINT MUTATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 33645800210     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J and Hamilton SR: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993.
2. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J and Lindblom A: Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258-261, 1994.
3. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
4. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ and Boland R: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer. Gastroenterology 104: 1535-1549, 1993.
5. Marra G and Boland R: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87: 1114-1125, 1995.
6. Peltomaki P and Vasen HFA: Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 113: 1146-1158, 1997.
7. Wijnen J, Vasen H, Meera-Khan PM, Menko F, van der Klift H, van Leeuwen C, van den Broek M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer A, Lidhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J and Fodde R: Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 56: 1060-1066, 1995.
8. Wijnen J, Meera-Khan PM, Vasen H, Menko F, van der Klift H, van den Broek, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer A, Lidhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Kolodner R and Fodde R: Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet 58: 300-307, 1996.
9. Wu Y, Nystrom-Lahti M, Osinga J, Looman MWG, Peltomaki P, Aaltonen LA, de la Chapelle A, Hofstraq RMW and Buys CHCM: MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 18: 269-278, 1997.
10. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994.
11. Eshleman JR and Markowitz D: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7: 83-89, 1995.
12. Cunningham JM, Shan A, Wick MJ, Bostwick DG and Thibodeau SN: Allelic inbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56: 4475-4482, 1996.
13. Kwok S and Higuchi R: Avoiding false positivities with PCR. Nature 339: 237-238, 1989.
14. Kaplan EL and Meier P: Non parametric estimation from incomplete observation. J Am Stat Assoc 53: 457-460, 1958.
15. Cox DR: Regression models and life tables. J Stat Soc B 34: 187-220, 1972.
16. Wildenberg J and Meselson M: Mismatch repair in heteroduplex DNA. Proc Natl Acad Sci USA 72: 2202-2206, 1975.
17. Korabiowska M, Dengler H, Kellner S, Stachura J and Schauer A. Decreased expression of MLH1, MSH2, PMS1 and PMS2 in pigmented lesions indicates accumulation of failed DNA repair along with malignant transformation and tumour progression. Oncol Rep 4: 653-655, 1997.
18. Korabiowska M, Brinck U, Dengler H, Stachura J, Schauer A and Droese M: Analysis of the DNA mismatch repair proteins expression in malignant melanomas. Anticancer Res 20: 4499-4506, 2000.
19. Korabiowska M, Ruschenburg I, Schlott T, Kubitz A, Brinck U and Droese M: Relation between DNA ploidy status and the expression of the DNA mismatch repair genes MLH1 and MSH2 in cytological specimens of melanoma lymph node and liver metastasis. Diagn Cytopathol 24: 157-162, 2001.
20. Korabiowska M, Viehöver M, Schlott T, Berger H, Droese M and Brinck U: Relationship between DNA ploidy related parameters and the deletions in mismatch repair genes MLH1 and MSH2 in lentigo maligna and malignant melanomas. Arch Dermatol Res 295: 219-225, 2001.
21. Korabiowska M, Brinck U, Kotthaus I, Berger H and Droese M: Comparative study of the expression of DNA mismatch repair genes, the adenomatous polyposis coli gene and growth arrest DNA damage genes in melanoma recurrences and metastases. Melanoma Res 10: 537-544, 2000.
22. Korabiowska M, Cordon-Cardo C, Jaenckel F, Stachura J, Fischer G and Brinck U: Application of in situ hybridization probes for MLH1 and MSH2 in tissue microarrays of paraffin embedded melanomas: correlation with immunohistochemistry and tumor stage. Hum Pathol 55: 1543-1548, 2004.
23. Korabiowska M, Schlott T, Siems N, Müller A, Cordon-Cardo C, Fischer G and Brinck U: Analysis of adenomatous polyposis coli gene expression, APC locus, MSI and APC promoter methylation in the progression of melanocytic tumours. Mod Pathol 17: 1539-1544, 2004.
24. Korabiowska M, Tscherny M, Stachura J, Berger H, Cordon-Cardo C and Brinck U: Differential expression of DNA nonhomologous end-joining proteins Ku70 and Ku80 in melanoma progression. Mod Pathol 15: 426-433, 2002.
25. Cunningham JE, Christensen EM, Tester DJ, Kim CY, Roche PC, Burgart LJ and Thibodeau SN: Hypermethylation of the MLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58: 3455-3460, 1998.
26. Deng G, Chen A, Hong J, Chae S and Kim YS: Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029-2033, 1999.
27. Morse HG, Moore GE, Ortiz LM, Gonzalez R and Robinson WA: Malignant melanoma: from subcutaneous nodule to brain metastases. Cancer Genet Cytogenet 72: 16-23, 1994.
28. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH and Becher R: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347: 1222-1225, 1996.
29. Prescher G, Bornfeld N and Becher R: Two subclones in a case of uveal melanoma. Relevance of monosomy 3 and multiplication of chromosome 8q. Cancer Genet Cytogenet 77: 144-146, 1994.
30. White VA, Chambers JD, Coutright PD, Chang WY and Horsman DE: Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83: 354-359, 1998.